CRI Lifetree Expert Lynn Webster, MD, to Discuss Human Abuse Liability at Drug Information Association Annual Meeting

Published: Jun 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

(Salt Lake City, Utah; June 12, 2013) — Dr. Lynn Webster, CRI Lifetree’s chief medical director and one of the country’s foremost authorities on pain clinical research and human abuse liability testing, will be sharing his HAL expertise during a workshop at the 2013 Drug Information Association Annual Meeting.

Webster will discuss “Human Abuse Liability Testing in CNS Drug Development” from 1:45 to 3:15 p.m. Tuesday, June 25 in room 156C.

“Human abuse liability data supplies critical information for a new drug application for most central nervous system drugs,” said Webster, MD. “This workshop will address the FDA’s guidance including the new guidance for products that may be scheduled under one of the four tiers of labeling in the Controlled Substances Act. We will discuss how to recognize when HAL studies are indicated, the appropriate goals for a study as well as correct methodology and regulatory considerations.”

CRI Lifetree, a leader in early stage clinical research, will be in booth #1613 at DIA, June 24-26 in Boston.

The company’s Salt Lake City facility is the country’s leading human abuse liability research clinic and has conducted more human abuse liability assessments than any other research center in the United States. Led by Webster, who recently was elected president of the American Academy of Pain Medicine, the center has a breadth of pain study expertise, including implementing human pain models to demonstrate efficacy early in the drug development process.

DIA attendees are invited to stop by booth #1613 to meet with Webster and CRI Lifetree’s experts to discuss human abuse liability and pain trials. To schedule a free consultation, email or or call the Salt Lake City Research Center at 801-269-8200.

About CRI Lifetree

CRI Lifetree is a leader in specialized, multi-therapeutic early stage research providing innovative solutions, high quality and timely results to sponsors. The company has significant expertise in pain disorders, human abuse liability testing, psychiatry and neurology, cognition and pediatrics. CRI Lifetree offers a broad range of Phase I-IV services and rapid access to specific patient populations to meet the requirements of complex clinical research programs. With sites in Marlton, N.J., Philadelphia and Salt Lake City, the company conducts inpatient and outpatient clinical research in special populations and healthy volunteers. For additional information, visit

Help employers find you! Check out all the jobs and post your resume.

Back to news